Blunt Business dives into the shifting landscape of American cannabis, from the halls of Congress to the microscopic world of medical research.
We break down the newly proposed CLIMB Act, a bipartisan bill aimed at finally opening major U.S. stock exchanges and private lending to state-sanctioned marijuana businesses.
While federal deregulation remains in a "ghost town" phase of waiting for DOJ action, we highlights how these financial hurdles currently stifle minority and veteran-owned entrepreneurs.